Back to Course

2025 PACUPrep BCCCP Preparatory Course

0% Complete
0/0 Steps
  1. Pulmonary

    ARDS
    4 Topics
    |
    1 Quiz
  2. Asthma Exacerbation
    4 Topics
    |
    1 Quiz
  3. COPD Exacerbation
    4 Topics
    |
    1 Quiz
  4. Cystic Fibrosis
    6 Topics
    |
    1 Quiz
  5. Drug-Induced Pulmonary Diseases
    3 Topics
    |
    1 Quiz
  6. Mechanical Ventilation Pharmacotherapy
    5 Topics
    |
    1 Quiz
  7. Pleural Disorders
    5 Topics
    |
    1 Quiz
  8. Pulmonary Hypertension (Acute and Chronic severe pulmonary hypertension)
    5 Topics
    |
    1 Quiz
  9. Cardiology
    Acute Coronary Syndromes
    6 Topics
    |
    1 Quiz
  10. Atrial Fibrillation and Flutter
    6 Topics
    |
    1 Quiz
  11. Cardiogenic Shock
    4 Topics
    |
    1 Quiz
  12. Heart Failure
    7 Topics
    |
    1 Quiz
  13. Hypertensive Crises
    5 Topics
    |
    1 Quiz
  14. Ventricular Arrhythmias and Sudden Cardiac Death Prevention
    5 Topics
    |
    1 Quiz
  15. NEPHROLOGY
    Acute Kidney Injury (AKI)
    5 Topics
    |
    1 Quiz
  16. Contrast‐Induced Nephropathy
    5 Topics
    |
    1 Quiz
  17. Drug‐Induced Kidney Diseases
    5 Topics
    |
    1 Quiz
  18. Rhabdomyolysis
    5 Topics
    |
    1 Quiz
  19. Syndrome of Inappropriate Antidiuretic Hormone (SIADH)
    5 Topics
    |
    1 Quiz
  20. Renal Replacement Therapies (RRT)
    5 Topics
    |
    1 Quiz
  21. Neurology
    Status Epilepticus
    5 Topics
    |
    1 Quiz
  22. Acute Ischemic Stroke
    5 Topics
    |
    1 Quiz
  23. Subarachnoid Hemorrhage
    5 Topics
    |
    1 Quiz
  24. Spontaneous Intracerebral Hemorrhage
    5 Topics
    |
    1 Quiz
  25. Neuromonitoring Techniques
    5 Topics
    |
    1 Quiz
  26. Gastroenterology
    Acute Upper Gastrointestinal Bleeding
    5 Topics
    |
    1 Quiz
  27. Acute Lower Gastrointestinal Bleeding
    5 Topics
    |
    1 Quiz
  28. Acute Pancreatitis
    5 Topics
    |
    1 Quiz
  29. Enterocutaneous and Enteroatmospheric Fistulas
    5 Topics
    |
    1 Quiz
  30. Ileus and Acute Intestinal Pseudo-obstruction
    5 Topics
    |
    1 Quiz
  31. Abdominal Compartment Syndrome
    5 Topics
    |
    1 Quiz
  32. Hepatology
    Acute Liver Failure
    5 Topics
    |
    1 Quiz
  33. Portal Hypertension & Variceal Hemorrhage
    5 Topics
    |
    1 Quiz
  34. Hepatic Encephalopathy
    5 Topics
    |
    1 Quiz
  35. Ascites & Spontaneous Bacterial Peritonitis
    5 Topics
    |
    1 Quiz
  36. Hepatorenal Syndrome
    5 Topics
    |
    1 Quiz
  37. Drug-Induced Liver Injury
    5 Topics
    |
    1 Quiz
  38. Dermatology
    Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
    5 Topics
    |
    1 Quiz
  39. Erythema multiforme
    5 Topics
    |
    1 Quiz
  40. Drug Reaction (or Rash) with Eosinophilia and Systemic Symptoms (DRESS)
    5 Topics
    |
    1 Quiz
  41. Immunology
    Transplant Immunology & Acute Rejection
    5 Topics
    |
    1 Quiz
  42. Solid Organ & Hematopoietic Transplant Pharmacotherapy
    5 Topics
    |
    1 Quiz
  43. Graft-Versus-Host Disease (GVHD)
    5 Topics
    |
    1 Quiz
  44. Hypersensitivity Reactions & Desensitization
    5 Topics
    |
    1 Quiz
  45. Biologic Immunotherapies & Cytokine Release Syndrome
    5 Topics
    |
    1 Quiz
  46. Endocrinology
    Relative Adrenal Insufficiency and Stress-Dose Steroid Therapy
    5 Topics
    |
    1 Quiz
  47. Hyperglycemic Crisis (DKA & HHS)
    5 Topics
    |
    1 Quiz
  48. Glycemic Control in the ICU
    5 Topics
    |
    1 Quiz
  49. Thyroid Emergencies: Thyroid Storm & Myxedema Coma
    5 Topics
    |
    1 Quiz
  50. Hematology
    Acute Venous Thromboembolism
    5 Topics
    |
    1 Quiz
  51. Drug-Induced Thrombocytopenia
    5 Topics
    |
    1 Quiz
  52. Anemia of Critical Illness
    5 Topics
    |
    1 Quiz
  53. Drug-Induced Hematologic Disorders
    5 Topics
    |
    1 Quiz
  54. Sickle Cell Crisis in the ICU
    5 Topics
    |
    1 Quiz
  55. Methemoglobinemia & Dyshemoglobinemias
    5 Topics
    |
    1 Quiz
  56. Toxicology
    Toxidrome Recognition and Initial Management
    5 Topics
    |
    1 Quiz
  57. Management of Acute Overdoses – Non-Cardiovascular Agents
    5 Topics
    |
    1 Quiz
  58. Management of Acute Overdoses – Cardiovascular Agents
    5 Topics
    |
    1 Quiz
  59. Toxic Alcohols and Small-Molecule Poisons
    5 Topics
    |
    1 Quiz
  60. Antidotes and Gastrointestinal Decontamination
    5 Topics
    |
    1 Quiz
  61. Extracorporeal Removal Techniques
    5 Topics
    |
    1 Quiz
  62. Withdrawal Syndromes in the ICU
    5 Topics
    |
    1 Quiz
  63. Infectious Diseases
    Sepsis and Septic Shock
    5 Topics
    |
    1 Quiz
  64. Pneumonia (CAP, HAP, VAP)
    5 Topics
    |
    1 Quiz
  65. Endocarditis
    5 Topics
    |
    1 Quiz
  66. CNS Infections
    5 Topics
    |
    1 Quiz
  67. Complicated Intra-abdominal Infections
    5 Topics
    |
    1 Quiz
  68. Antibiotic Stewardship & PK/PD
    5 Topics
    |
    1 Quiz
  69. Clostridioides difficile Infection
    5 Topics
    |
    1 Quiz
  70. Febrile Neutropenia & Immunocompromised Hosts
    5 Topics
    |
    1 Quiz
  71. Skin & Soft-Tissue Infections / Acute Osteomyelitis
    5 Topics
    |
    1 Quiz
  72. Urinary Tract and Catheter-related Infections
    5 Topics
    |
    1 Quiz
  73. Pandemic & Emerging Viral Infections
    5 Topics
    |
    1 Quiz
  74. Supportive Care (Pain, Agitation, Delirium, Immobility, Sleep)
    Pain Assessment and Analgesic Management
    5 Topics
    |
    1 Quiz
  75. Sedation and Agitation Management
    5 Topics
    |
    1 Quiz
  76. Delirium Prevention and Treatment
    5 Topics
    |
    1 Quiz
  77. Sleep Disturbance Management
    5 Topics
    |
    1 Quiz
  78. Immobility and Early Mobilization
    5 Topics
    |
    1 Quiz
  79. Oncologic Emergencies
    5 Topics
    |
    1 Quiz
  80. End-of-Life Care & Palliative Care
    Goals of Care & Advance Care Planning
    5 Topics
    |
    1 Quiz
  81. Pain Management & Opioid Therapy
    5 Topics
    |
    1 Quiz
  82. Dyspnea & Respiratory Symptom Management
    5 Topics
    |
    1 Quiz
  83. Sedation & Palliative Sedation
    5 Topics
    |
    1 Quiz
  84. Delirium Agitation & Anxiety
    5 Topics
    |
    1 Quiz
  85. Nausea, Vomiting & Gastrointestinal Symptoms
    5 Topics
    |
    1 Quiz
  86. Management of Secretions (Death Rattle)
    5 Topics
    |
    1 Quiz
  87. Fluids, Electrolytes, and Nutrition Management
    Intravenous Fluid Therapy and Resuscitation
    5 Topics
    |
    1 Quiz
  88. Acid–Base Disorders
    5 Topics
    |
    1 Quiz
  89. Sodium Homeostasis and Dysnatremias
    5 Topics
    |
    1 Quiz
  90. Potassium Disorders
    5 Topics
    |
    1 Quiz
  91. Calcium and Magnesium Abnormalities
    5 Topics
    |
    1 Quiz
  92. Phosphate and Trace Electrolyte Management
    5 Topics
    |
    1 Quiz
  93. Enteral Nutrition Support
    5 Topics
    |
    1 Quiz
  94. Parenteral Nutrition Support
    5 Topics
    |
    1 Quiz
  95. Refeeding Syndrome and Specialized Nutrition
    5 Topics
    |
    1 Quiz
  96. Trauma and Burns
    Initial Resuscitation and Fluid Management in Trauma
    5 Topics
    |
    1 Quiz
  97. Hemorrhagic Shock, Massive Transfusion, and Trauma‐Induced Coagulopathy
    5 Topics
    |
    1 Quiz
  98. Burns Pharmacotherapy
    5 Topics
    |
    1 Quiz
  99. Burn Wound Care
    5 Topics
    |
    1 Quiz
  100. Open Fracture Antibiotics
    5 Topics
    |
    1 Quiz

Participants 432

  • Allison Clemens
  • April
  • ababaabhay
  • achoi2392
  • adhoward1
Show more
Lesson Progress
0% Complete
Foundational Principles, Pathophysiology, and Epidemiology of Trauma-Induced Hypovolemia

Foundational Principles, Pathophysiology, and Epidemiology of Trauma-Induced Hypovolemia

Objective Icon A target symbol representing learning goals.

Objective

Describe global impact, mechanistic pathways, and early resuscitation principles for trauma-induced hypovolemia and hemorrhagic shock.

1. Epidemiology and Clinical Impact

Uncontrolled hemorrhage is a leading cause of preventable death worldwide, driving most early mortality after severe injury. Trauma accounts for approximately 10% of the global burden of disease, and up to one-third of critically ill trauma patients require emergent volume resuscitation. Early recognition and targeted prehospital interventions, such as permissive hypotension, can dramatically reduce mortality.

A. Global Burden and Prehospital Care

  • Hemorrhagic shock is the primary driver of preventable death in trauma patients.
  • In settings where transport times exceed 30 minutes, prehospital administration of balanced crystalloids has been shown to reduce mortality.
  • Rural and low-resource settings face significantly higher mortality rates due to prolonged shock duration and limited access to advanced prehospital care.

B. Permissive Hypotension

This strategy aims to minimize ongoing hemorrhage by avoiding high blood pressures that can dislodge early clots, while still maintaining perfusion to vital organs. The target systolic blood pressure (SBP) varies by injury pattern.

Permissive Hypotension Targets in Trauma
Injury Pattern Target SBP Rationale
Penetrating Torso Injury 60–70 mmHg Minimizes non-compressible torso hemorrhage.
Blunt Trauma (without TBI) 80–90 mmHg Balances systemic perfusion with bleeding control.
Blunt Trauma with TBI 100–110 mmHg Maintains cerebral perfusion pressure (CPP).
Pearl Icon A shield with an exclamation mark, indicating a clinical pearl. Clinical Pearl: Impact in Austere Environments +

Implementing basic prehospital interventions, such as establishing IV access and adhering to permissive hypotension protocols, can lower mortality by up to 20% in austere or resource-limited environments.

2. Pathophysiology and Coagulopathy

Acute blood loss triggers a cascade of compensatory mechanisms, including vasoconstriction and tachycardia. However, if hypoperfusion persists, it leads to cellular injury, metabolic acidosis, profound endothelial disruption, and the development of trauma-induced coagulopathy (TIC), a lethal combination that worsens bleeding and complicates resuscitation.

Pathophysiology of Hemorrhagic Shock A flowchart showing the progression from acute blood loss to trauma-induced coagulopathy. Key steps include compensatory responses, cellular injury, and endothelial dysfunction. Acute Blood Loss (↓ Preload) Compensatory Response (↑HR, SVR) Cellular Injury (Lactate, Acidosis) Endothelial Dysfunction Trauma-Induced Coagulopathy (TIC)
Figure 1: Pathophysiologic Cascade of Hemorrhagic Shock. Initial compensatory mechanisms are overwhelmed by persistent hypoperfusion, leading to cellular injury and endothelial damage, which culminates in trauma-induced coagulopathy.
  • Cellular Effects: A shift to anaerobic metabolism results in lactate accumulation and metabolic acidosis. Subsequent reperfusion can cause further oxidative stress and tissue damage.
  • Endothelial Dysfunction: Degradation of the protective endothelial glycocalyx leads to capillary leak, interstitial edema, and the release of endogenous anticoagulants, which fuels the coagulopathy.
  • Trauma-Induced Coagulopathy Spectrum: This condition can manifest as early hyperfibrinolysis (excessive clot breakdown) or late fibrinolysis shutdown (prothrombotic state). Both extremes are associated with increased mortality.
Pearl IconA shield with an exclamation mark, indicating a clinical pearl. Clinical Pearl: The Endothelial Glycocalyx +

Protecting the endothelial glycocalyx is a promising therapeutic target. Strategies that minimize endothelial injury, such as early plasma-based resuscitation, may mitigate coagulopathy and reduce capillary leak, thereby improving outcomes.

3. Risk Factors and Comorbidities

Patient-specific factors, including pre-existing organ dysfunction, age, and socioeconomic determinants, significantly alter physiologic responses to trauma and access to care, thereby influencing shock severity and outcomes.

  • Cardiac Dysfunction: Patients with heart failure have limited tolerance for rapid volume shifts and are at high risk of iatrogenic pulmonary edema during aggressive resuscitation.
  • Renal Impairment: The use of chloride-rich fluids (e.g., normal saline) can exacerbate acute kidney injury (AKI). Balanced crystalloids are preferred to mitigate this risk.
  • Chronic Liver Disease: These patients often have a baseline relative hypovolemia. Procedures like large-volume paracentesis require concurrent albumin administration to maintain circulatory function.
  • Social Determinants of Health: Factors such as low health literacy, delayed activation of emergency medical services, and transport challenges can prolong the duration of shock and increase the rate of preventable deaths.
Controversy IconA chat bubble with a question mark, indicating a point of controversy or debate. Contraindication: Hydroxyethyl Starch (HES) +

The use of hydroxyethyl starch (HES) colloids for volume resuscitation in critically ill patients, including trauma, is strongly discouraged. Multiple large clinical trials have demonstrated an association with increased mortality and a higher incidence of acute kidney injury requiring renal replacement therapy.

Pearl IconA shield with an exclamation mark, indicating a clinical pearl. Clinical Pearl: Fluid Choice in Renal Disease +

Even in patients with pre-existing chronic kidney disease, balanced crystalloids (e.g., Lactated Ringer’s, Plasma-Lyte) are preferred over normal saline. This choice helps preserve renal perfusion and avoids the hyperchloremic metabolic acidosis associated with large volumes of saline.

4. Clinical Presentation and Early Recognition

Classic vital signs and simple physical exam findings are the cornerstones of initial triage and activation of early warning systems. However, a multimodal assessment that incorporates these findings with trauma-specific criteria is necessary to accelerate diagnosis and intervention.

A. Key Signs and Symptoms

  • Vital Signs: Tachycardia, hypotension, and a narrowing pulse pressure (the difference between systolic and diastolic pressure) are classic indicators. Altered mental status, ranging from agitation to obtundation, is a critical sign of cerebral hypoperfusion.
  • Physical Exam: Cool, clammy, or mottled skin reflects compensatory peripheral vasoconstriction. A delayed capillary refill time (>2 seconds) and oliguria (low urine output) are further signs of end-organ malperfusion.

B. Triage and Warning Scores

The integration of early warning scores, such as the National Early Warning Score (NEWS) or Modified Early Warning Score (MEWS), with trauma-specific criteria can help standardize care and trigger immediate evaluation by a trauma team. These scores assign points to abnormal vital signs, allowing for rapid identification of deteriorating patients.

5. Foundations of Initial Resuscitation

Modern trauma resuscitation has shifted to a strategy known as damage control resuscitation (DCR). This approach prioritizes early hemorrhage control, limits crystalloid administration, employs permissive hypotension, and mandates a rapid transition to balanced blood product transfusion to correct coagulopathy and restore oxygen-carrying capacity.

A. Principles of Damage Control Resuscitation (DCR)

  1. Early Hemorrhage Control: The absolute priority is to stop the bleeding, whether through direct pressure, tourniquets, surgical intervention, or interventional radiology.
  2. Minimize Crystalloids: Limit initial crystalloid administration to less than 1–2 liters to avoid dilutional coagulopathy, acidosis, and hypothermia before hemostatic resuscitation begins.
  3. Permissive Hypotension: Adhere to targeted blood pressure goals based on the injury pattern to prevent dislodging nascent clots.
  4. Balanced Transfusion: Rapidly initiate transfusion with a balanced ratio of plasma, platelets, and packed red blood cells (pRBCs), typically 1:1:1, to mimic whole blood and treat coagulopathy.

B. Fluid Selection and Monitoring

  • First-Line Fluid: Balanced crystalloids are the initial fluid of choice to avoid hyperchloremic acidosis and reduce the risk of AKI.
  • Contraindicated Fluid: Colloids like HES are contraindicated. Albumin is generally reserved for use after hemorrhage is controlled.
  • Monitoring Endpoints: Resuscitation is guided by a combination of clinical signs (bleeding control, mental status), laboratory values (hemoglobin, lactate, coagulation panel), and dynamic measures (ultrasound, arterial waveform analysis).
Pearl IconA shield with an exclamation mark, indicating a clinical pearl. Clinical Pearl: Time to Plasma is Critical +

Initiating balanced blood product resuscitation within the first 30 minutes of arrival is crucial. Studies have shown that for every 5-unit delay in administering plasma relative to red blood cells, the odds of death increase by approximately 10%.

References

  1. Ramesh GH, Uma JC, Farhath S. Fluid resuscitation in trauma: what are the best strategies and fluids? Int J Emerg Med. 2019;12:38.
  2. Murad MK, Larsen S, Husum H. Prehospital trauma care reduces mortality. Scand J Trauma Resusc Emerg Med. 2012;20:13.
  3. Rossaint R, Bouillon B, Cerny V, et al. The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition. Crit Care. 2016;20:100.
  4. Fecher A, Huber-Lang M, Windolf J, Frink M. The pathophysiology and management of hemorrhagic shock. J Clin Med. 2021;10(21):4884.
  5. Hinojosa-Laborde C, Baldwin K, Baker MG. Pathophysiology of hemorrhage as it relates to the trauma patient. Physiology (Bethesda). 2022;37(2):103-114.
  6. Yunos NM, Bellomo R, Hegarty C, Story D, Ho L, Bailey M. Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA. 2012;308(15):1566-1572.
  7. Myburgh JA, Finfer S, Bellomo R, et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med. 2012;367(20):1901-1911.
  8. Bickell WH, Wall MJ, Pepe PE, et al. Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries. N Engl J Med. 1994;331(17):1105-1109.